Kite’s cell therapy manufacturing facility is strategically located next to Schiphol Airport.
From Hoofddorp, Kite produces cell therapy for more than 300 specialized treatment centers within and outside Europe.
Our manufacturing facility in Hoofddorp is one of the locations within Kite’s global production network.
Within this global network of manufacturing facilities, we deliver cell therapies quickly and reliably to specialized treatment centers around the world. As we continue to grow and expand, we invest in manufacturing and technological innovations that will help us meet the future needs.
Reporting adverse events or side effects after a medicine has been placed on the market is important. These reports ensure that the risk-benefit profile of a medicine can be continuously monitored. Healthcare professionals and patients are asked to report all adverse events or side effects via www.fagg-afmps.be (for Belgium), www.guichet.public.lu/en/entreprises/sectoriel/sante/medecins/notification-effets-indesirables-medicaments.html (for Luxembourg) or www.lareb.nl (for the Netherlands). Adverse events or side effects can also be reported directly to the marketing authorization holder of the medicine. Adverse events or side effects that may be related to a Gilead medicine can be reported to Gilead via email at [email protected].
Gilead Sciences Netherlands BV, Claude Debussylaan 22, 1082 MD Amsterdam, The Netherlands. Tel: +31 (0)
20 718 3650.
Medical Information: [email protected]
Gilead Sciences Belgium BV, Culliganlaan, 2D, 1831 Diegem, Belgium, Tel: +32 (0) 2 401 35 50 - VAT
number: 0882 565 584.
Medical Information: [email protected]
BE-UNB-1825 | Date of preparation: February 2026